Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL [Phase 2]
A Phase 2 clinical trial update indicates Ascentage Pharma is evaluating APG-115 alone or with APG-2575 in relapsed/refractory T-cell prolym…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Auto Stem Cell Transplant for Lymphoma Patients [Phase 2]
This Phase 2 clinical trial registry entry describes autologous stem cell transplantation as a treatment approach for non-Hodgkin lymphoma a…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) [Phase 1]
Phase 1 trial evaluating autologous/allogeneic TGF-beta-resistant LMP-specific cytotoxic T lymphocytes for lymphoma; the study is active but…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Two Step Haplo With Radiation Conditioning [Phase 2]
Phase 2 clinical trial update describing two-step haploidentical transplantation with radiation conditioning for hematologic diseases, curre…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors [Phase 1]
Phase 1 pediatric trial evaluating alpha/beta CD19+ depleted haploidentical transplantation in combination with Zoledronic acid (Zometa) for…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Family Study of Lymphoproliferative Disorders
A Mayo Clinic-led clinical trial is a family study investigating lymphoproliferative disorders, currently in the recruitment phase.
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) [Phase 1]
This clinical trial update reports the Phase 1 study of JNJ-75348780 in participants with Non-Hodgkin lymphoma and chronic lymphocytic leuke…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma [Phase 1]
Treeline Biosciences is conducting a Phase 1 study of TLN-254 in participants with relapsed or refractory T-cell lymphoma, currently recruit…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig) [Phase 2, Phase 3]
Clinical trial update for the Stop Ig study, assessing whether antibiotic therapy or immunoglobulin use affects infection management and dec…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig) [Phase 2, Phase 3]
A Monash University trial is testing antibiotic therapy or intravenous immunoglobulin dosing to prevent infections in hematologic cancer pat…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) [Phase 2, Phase 3]
A hematology platform trial (RATIONAL-PT) is evaluating the roles of antibiotic therapy or immunoglobulin for infections in patients with he…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma [Phase 1]
This update outlines a Phase 1 study of genetically modified T-cell infusions following peripheral blood stem cell transplant for patients w…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial [Phase 3]
Adaptive Phase 3 trial assessing optimized COVID-19 vaccination schedules for immunocompromised individuals, including patients with HIV and…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Expanded Access program for AVM0703 is available to eligible patients with several solid tumor and blood cancer indications, including gliob…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies [Phase 1, Phase 2]
This clinical trial listing indicates that GNC-035 is being studied in relapsed or refractory non-Hodgkin lymphoma and other hematologic mal…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial update describes an ongoing Phase 1/2 study of selinexor in combination chemotherapy for advanced B-cell non-Hodgkin lymphoma…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the combination of nivolumab and lenalidomide in relapsed or refractory lymphomas (non-Hodgkin an…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL [Phase 2]
A Phase 2 clinical trial evaluating the combination of linperlisib with cyclophosphamide, prednisone, and thalidomide (CPT) for relapsed/ref…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of GNC-038 Injection in adults with relapsed or refractory Non-Hodgkin lymphoma, curr…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation [Phase 3]
A Phase 3 trial compares zanubrutinib plus rituximab against bendamustine plus rituximab in adults with previously untreated mantle cell lym…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies [EARLY_Phase 1]
An early-phase trial evaluating Darzalex Faspro (daratumumab and hyaluronidase-fihj) given before desensitization and allogeneic stem cell t…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL [Phase 1, Phase 2]
Clinical trial update for GNC-038 injection in Phase 1/2 studies for relapsed or refractory NK/T-cell lymphoma and Non-Hodgkin lymphoma, wit…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia [Phase 1]
Phase I clinical trial update for GNC-038 in non-Hodgkin lymphoma and acute lymphoblastic leukemia; the study is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma [Phase 1]
This Phase 1 trial evaluates low-dose radiation as bridging therapy for relapsed or refractory B-cell non-Hodgkin lymphomas, including DLBCL…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel [Phase 1]
Phase 1 clinical trial evaluating the safety of reinfusing axicabtagene ciloleucel (Axi-Cel-2) in patients with relapsed/refractory second-l…